Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | FBP1 | P09467 | 1/20 | 0.30 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17992 | 0.80 | TRPV4 (0.42) | LMNAMAPK1 | |
| SCHEMBL18297519 | 0.79 | L3MBTL1 (0.35) | MAPK1HTTTUBB1 | |
| SCHEMBL31362459 | 0.79 | EGFR (0.32) | LMNAEGFR | |
| SCHEMBL2336780 | 0.78 | TRPV4 (0.33) | — | |
| SCHEMBL17417563 | 0.72 | TAAR1 (0.45) | MAOB | |
| SCHEMBL15243966 | 0.72 | TUBB1 (0.32) | TUBB1 | |
| SCHEMBL29005932 | 0.72 | PDE2A (0.32) | EGFRFBP1TUBB1 | |
| SCHEMBL15391492 | 0.72 | NFE2L2 (0.43) | NFE2L2LMNAMAPK1 | |
| SCHEMBL10086105 | 0.72 | TUBB1 (0.42) | MAOBNFE2L2LMNAMAPK1HTT | |
| SCHEMBL4882783 | 0.71 | LMNA (0.32) | MAOBNFE2L2LMNAMAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025034858-A1 | FUSED PYRIDINES FOR THE TREATMENT OF CANCER AND OTHER INDICATIONS | THERAS, INC. (US) | 2025-02-13 | — | — | WO | disclosed |